stockrow
Friday 6 November 2026
Export STAA’s income statement to Excel — free account
STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
STAAR Surgical Company’s revenue for fiscal 2025 (year ended December 2025) was $239.4 million, down 23.7% from fiscal 2024.
- Revenue
- −12.0%
- EPS
- −38.9%
- Free cash flow
- +1,378.7%
Quarter to September 2026, against a year earlier
25.93
0.79
−2.96%
Follow STAA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 66.07 | 64.06 | 155.54 | 677.09 | 113.45 | 306.53 | 0.00 | 0.00 |
Piotroski F-Score |
2 | 3 | 3 | 6 | 7 | 5 | 6 | 7 | 7 | 4 |
P/S ratio |
4.78 | 3.80 | 4.47 | 8.65 | 18.70 | 22.10 | 10.42 | 10.96 | 7.20 | 5.23 |
Altman Z-Score |
6.44 | 7.43 | 10.30 | 18.44 | 30.96 | 36.81 | 20.47 | 23.81 | 13.71 | 7.26 |
Altman Z″-Score (non-manufacturers) |
4.46 | 6.95 | 8.05 | 8.51 | 6.93 | 6.36 | 6.11 | 6.06 | (2.93) | (4.93) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 140.34 | 142.56 | 289.86 | 100.20 | 129.15 | 360.80 | 0.00 |
P/Operating CF |
(292.42) | 1,858.64 | 45.12 | 828.06 | 507.21 | 184.80 | 159.79 | 579.51 | 586.30 | 3,371.25 |
Beneish M-Score |
(3.29) | (3.06) | (2.02) | (1.91) | (2.14) | (2.59) | (1.78) | (2.38) | (2.70) | (3.46) |
P/B ratio |
3.33 | 3.00 | 3.74 | 7.32 | 16.67 | 18.32 | 9.79 | 10.26 | 15.18 | 11.38 |
Price to Tangible BV |
3.34 | 3.02 | 3.76 | 7.36 | 16.80 | 18.51 | 9.92 | 10.42 | 15.95 | 12.11 |
EV/Sales |
4.13 | 3.07 | 3.79 | 7.90 | 17.84 | 21.17 | 9.62 | 10.13 | 7.00 | 5.08 |
EV/EBITDA |
0.00 | 0.00 | 39.78 | 47.71 | 111.16 | 350.81 | 92.93 | 138.60 | 0.00 | 0.00 |
EV/Operating CF |
(28.91) | 61.23 | 83.73 | 62.94 | 93.51 | 165.17 | 56.03 | 98.34 | 222.21 | 399.29 |
EV/FCF |
(24.65) | (124.20) | (332.31) | 128.28 | 135.97 | 277.63 | 92.54 | 119.32 | 350.84 | (194.28) |
Quick Ratio |
3.47 | 4.39 | 4.85 | 5.30 | 4.98 | 4.55 | 4.38 | 4.68 | 1.91 | 1.44 |
Current Ratio |
4.55 | 5.23 | 5.62 | 6.03 | 5.56 | 5.25 | 5.07 | 5.47 | 2.82 | 2.35 |
Net Debt/EBITDA |
2.25 | 33.84 | (7.18) | (4.49) | (5.39) | (15.45) | (7.69) | (11.42) | 64.94 | 1.30 |
Debt/Assets |
0.00% | 0.00% | 0.01% | 0.05% | 0.11% | 0.01% | 0.18% | 0.27% | 0.78% | 2.04% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
Asset Turnover |
0.50 | 0.63 | 0.71 | 0.74 | 0.76 | 0.70 | 0.80 | 1.05 | 1.36 | 1.28 |
Operating CF/Net income |
0.43 | (0.78) | 0.68 | 0.90 | 1.60 | 3.54 | 1.84 | 2.57 | (1.33) | (0.09) |
Capex/Depreciation |
(0.68) | (4.03) | (6.93) | (5.47) | (3.75) | (2.72) | (2.75) | (0.91) | (0.31) | (1.11) |
Interest Coverage |
— | — | — | 17.89 | — | 28.44 | 12.00 | 39.97 | — | — |
| (21.70%) | (5.16%) | 5.91% | 13.34% | 12.07% | 3.31% | 9.61% | 5.67% | (5.29%) | (31.61%) | |
| (16.74%) | (4.05%) | 4.70% | 10.38% | 9.12% | 2.54% | 7.50% | 4.22% | (3.21%) | (18.89%) | |
ROIC |
(36.59%) | (4.72%) | 10.63% | 21.96% | 35.18% | 9.44% | 18.39% | 14.21% | (9.10%) | (31.33%) |
Return on Tangible Assets |
(25.43%) | (5.28%) | 5.82% | 12.76% | 10.64% | 2.97% | 8.93% | 3.67% | (4.80%) | (30.14%) |
Average Days of Receivables |
76.32 | 90.58 | 107.21 | 80.15 | 68.94 | 78.67 | 75.33 | 76.40 | 71.92 | 72.37 |
Research and Development Expense of Revenue |
16.73% | 14.44% | 12.55% | 12.65% | 14.69% | 19.53% | 16.84% | 17.77% | 22.12% | 25.07% |
Selling, General and Administrative Expense of Revenue |
78.65% | 65.90% | 57.09% | 50.49% | 48.35% | 48.74% | 49.81% | 50.73% | 52.83% | 61.09% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
12.77% | 8.67% | 7.29% | 7.16% | 6.34% | 7.43% | 7.02% | 5.46% | 3.49% | 10.38% |
Graham Net Nets |
0.18 | 0.21 | 0.18 | 0.09 | 0.04 | 0.04 | 0.08 | 0.09 | 0.04 | 0.05 |
Graham Number |
0.00 | 0.00 | 8.97 | 11.23 | 8.51 | 3.37 | 5.01 | 2.70 | 0.00 | 0.00 |
Earnings Yield |
(7.06%) | (1.69%) | 1.51% | 1.56% | 0.64% | 0.15% | 0.88% | 0.33% | (0.27%) | (2.71%) |
Free Cash Flow Yield |
(3.51%) | (0.65%) | (0.25%) | 0.71% | 0.70% | 0.34% | 1.00% | 0.77% | 0.28% | (0.50%) |
Revenue per Share |
4.83 | 6.39 | 6.64 | 5.93 | 4.88 | 3.58 | 3.38 | 2.91 | 2.21 | 2.04 |
Operating CF per Share |
(0.69) | 0.32 | 0.30 | 0.74 | 0.93 | 0.46 | 0.58 | 0.30 | 0.07 | 0.03 |
Capex per Share |
(0.12) | (0.48) | (0.37) | (0.38) | (0.29) | (0.18) | (0.23) | (0.05) | (0.03) | (0.08) |
Free Cash Flow per Share |
(0.81) | (0.16) | (0.07) | 0.37 | 0.64 | 0.28 | 0.35 | 0.25 | 0.04 | (0.05) |
Cash per Share |
3.78 | 4.69 | 4.55 | 4.41 | 4.23 | 3.34 | 2.70 | 2.44 | 0.45 | 0.35 |
Shareholders Equity per Share |
6.94 | 8.09 | 7.95 | 7.00 | 5.48 | 4.32 | 3.59 | 3.11 | 1.05 | 0.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.94 | 8.09 | 7.95 | 7.00 | 5.48 | 4.32 | 3.59 | 3.11 | 1.05 | 0.94 |
Free Cash Flow |
(40.05) | (7.67) | (3.59) | 17.61 | 30.32 | 12.55 | 15.62 | 10.52 | 1.81 | (2.16) |
Working Capital |
243.04 | 297.63 | 300.23 | 260.01 | 222.61 | 175.18 | 140.19 | 123.84 | 34.80 | 28.45 |
Capital Expenditures |
(5.82) | (23.39) | (18.19) | (18.11) | (13.64) | (8.40) | (10.18) | (2.24) | (1.05) | (3.20) |
Net Current Asset Value |
204.05 | 255.75 | 262.53 | 229.02 | 184.19 | 156.22 | 127.03 | 116.66 | 28.89 | 21.95 |
EV/EBIT |
0.00 | 0.00 | 43.49 | 51.32 | 123.31 | 511.21 | 121.94 | 190.38 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.07 | 0.02 | 0.01 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 51.34 | 56.15 | 129.29 | 533.73 | 132.03 | 206.06 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.07 | 0.04 | 0.07 | 0.10 | 0.13 | 0.22 | 0.22 | 0.34 | 0.25 |
Cash ROIC |
(7.53%) | (1.22%) | (0.59%) | 3.21% | 6.61% | 3.59% | 5.57% | 4.44% | 2.92% | (4.05%) |
Accounts Receivable Turnover |
3.74 | 3.64 | 4.10 | 5.37 | 5.85 | 4.94 | 5.28 | 5.66 | 5.30 | 5.15 |
Accounts Payable Turnover |
4.03 | 4.91 | 5.55 | 6.02 | 6.41 | 5.81 | 5.25 | 5.17 | 3.67 | 3.21 |
Inventory Turnover |
1.15 | 1.90 | 2.35 | 2.94 | 2.93 | 2.56 | 2.26 | 2.16 | 1.87 | 1.57 |
Average Days of Payables |
74.09 | 82.04 | 70.93 | 69.26 | 61.25 | 60.49 | 76.86 | 73.40 | 83.63 | 126.07 |
Days of Inventory on Hand |
355.23 | 212.68 | 183.80 | 144.55 | 121.64 | 146.58 | 163.66 | 187.92 | 184.50 | 224.87 |
Average Receivables |
63.98 | 86.30 | 78.58 | 52.99 | 39.38 | 33.11 | 28.47 | 21.90 | 17.10 | 16.01 |
Average Payables |
14.14 | 15.13 | 12.57 | 10.14 | 8.09 | 7.76 | 7.29 | 6.28 | 7.17 | 7.50 |
Average Inventory |
49.40 | 39.22 | 29.65 | 20.72 | 17.69 | 17.63 | 16.92 | 15.01 | 14.07 | 15.37 |
Average Assets |
480.60 | 499.11 | 453.76 | 382.30 | 301.60 | 232.47 | 187.43 | 117.64 | 66.70 | 64.22 |
Average Common Equity |
370.76 | 391.64 | 361.03 | 297.34 | 227.89 | 178.55 | 146.16 | 87.68 | 40.42 | 38.38 |
Columns are period end dates · fundamentals updated 4 Nov 2026